Expanded Access through PEAPS
Our Pet Early Access Programs (PEAPS) connect pets and vets with groundbreaking treatment options that may have been otherwise unobtainable. We advocate for responsible extra-label drug use, harnessing the full potential of available medications to address complex medical challenges.
Extra-label drug use in veterinary medicine offers a vital lifeline for animals facing complex health issues.
Veterinarians can tailor treatments to suit individual patient needs, often when no other options are available. This flexibility allows for innovative approaches in managing conditions ranging from chronic diseases to emergent crises, providing hope and relief where conventional therapies fall short. Additionally, extra-label drug use fosters collaboration between veterinarians, pharmacologists, and researchers, driving forward our understanding of how to best serve our animal companions.
With careful oversight and adherence to established guidelines, this practice opens doors to new possibilities in veterinary care, ultimately enhancing the quality of life for countless beloved pets around the world.
Innovative therapies treating:
Feline Infectious Peritonitis (FIP)
Mast Cell Tumors
Diabetes
Cappalaria Worms
Other pet specific needs